Susan G. Komen for the Cure will support 80 cancer research programs with $55 million this year. The money will go to 56 institutions across the U.S., and over $1.2 million will be invested in projects outside the U.S., according to Genetic Engineering and Biotechnology News.

Grant amounts range from $120,000 to $600,000 plus two awards of $6.5 million each. These larger grants are going to the University of California, San Francisco, to test a treatment for triple-negative breast cancer, and Washington University in St. Louis, to develop a personalized breast cancer vaccine to prevent recurrence.

Komen reports that 40% of the funding will be invested in projects focused on finding the underlying origins of breast cancer and why it has the ability to metastasize. Almost 22% will go toward early detection, and about 20% will be invested in new treatments.